Table 1 Characteristics of patients treated for vulvar squamous cell carcinoma (vSCC) from January 2006 to December 2016 (AWD, alive with the disease; DOD, dead of disease; DOID, dead of intercurrent disease; NED, no evidence of disease)
Variables | (n = 165) |
|---|---|
Age median (years) (range) | 71 (34–94) |
Stage (FIGO 2009) (%) | |
 IA | 29 (17.6) |
 IB | 63 (38.2) |
 II | 24 (14.5) |
 IIIA | 19 (11.5) |
 IIIB | 14 (8.5) |
 IIIC | 15 (9.1) |
 IV | 1 (0.6) |
Tumor size (mm) (range) | 40 (17–140) |
Surgery (%) | |
 Radical local excision | 11 (6.7) |
 Radical vulvectomy | 49 (29.7) |
 Radical vulvectomy + LN dissection | 105 (63.6) |
 Radical vulvectomy + RT | 60 (36.4) |
 Radical vulvectomy + LN dissection + RT | 52 (31.5) |
Recurrence site (%) | |
 Local | 29 (17.6) |
 Regional | 11 (6.7) |
 Local-regional + distant | 4 (2.4) |
 Distant | 1 (0.6) |
Prognosis | |
 NED | 84 (50.9) |
 AWD | 17 (10.3) |
 DOD | 39 (23.6) |
 DOID | 25 (15.2) |
 Follow-up period (months) | 85 (10–156) |